Public Health Alerts

  • Discontinuation of Provincial COVID-19 Test Results Viewer

    To: Ottawa Physicians
    Date: September 2, 2025
    From: Dr. Laura Bourns, Deputy Medical Officer of Health
    Subject: Discontinuation of Provincial COVID-19 Test Results Viewer

    Dear Colleagues,

    Please see below a memo from Ontario’s Chief Medical Officer of Health regarding the discontinuation of the provincial COVID-19 Test Results Viewer.

  • Market Withdrawal of COVID-19 KP.2 vaccines

    To: Ottawa Physicians
    Date: August 29, 2025
    From: Dr. Laura Bourns, Deputy Medical Officer of Health
    Subject: Market Withdrawal of COVID-19 KP.

  • First Ottawa human case of West Nile Virus in 2025

    To: Ottawa Physicians and Nurse Practitioners
    Date: Aug 27, 2025
    From: Dr. Robin Taylor, Associate Medical Officer of Health

    Dear Colleagues,

    Ottawa Public Health (OPH) is writing to heighten your awareness of the possibility of illness from West Nile virus (WNV) infection in Ottawa, as the first human case of WNV has been reported in an Ottawa resident for the 2025 season.

  • Updated PHO AEFI Reporting Form

    To: Ottawa Physicians and Nurse Practitioners 
    Date: August 20, 2025
    From: Dr. Laura Bourns, Deputy Medical Officer of Health
    Subject: Updated PHO AEFI Reporting Form

    Dear Colleagues,

    In Ontario, Public Health Ontario (PHO) leads the provincial surveillance of adverse events following immunization (AEFIs).

  • Rabies Vaccine and Immunoglobulin Supply

    To: Ottawa Physicians and Nurse Practitioners 
    Date: August 18, 2025
    From: Dr. Michelle Foote, Associate Medical Officer of Health
    Subject: Rabies Vaccine and Immunoglobulin Supply

    Dear Colleagues,

    Ontario is experiencing a shortage of rabies vaccines and rabies immunoglobulins (RabIg).

  • Confirmed case of measles in Ottawa

    To: Ottawa Physicians and Nurse Practitioners 
    Date: August 14, 2025
    From: Dr. Michelle Foote, Associate Medical Officer of Health
    Subject: Confirmed case of measles in Ottawa

    Dear Colleagues,

    A case of measles has been reported to Ottawa Public Health with potential exposures to the virus for others in the community.

  • West Nile virus confirmed in Ottawa area mosquitoes 2025

    To: Ottawa Physicians and Nurse Practitioners 
    Date: August 12, 2025
    From: Dr. Monir Taha, Associate Medical Officer of Health
    Subject: West Nile virus confirmed in Ottawa area mosquitoes

    Dear Colleagues,

    Ottawa Public Health (OPH) is writing to heighten your awareness of the possibility of illness from West Nile virus (WNV) infection in Ottawa.

  • Syphilis testing update and screening recommendations

    To: Ottawa Physicians and Nurse Practitioners
    Date: July 29, 2025
    From: Dr. Michelle Foote, Associate Medical Officer of Health
    Subject: Syphilis testing update and screening recommendations

    Public Health Ontario Laboratory (PHOL) has updated its testing approach for syphilis lesion specimens.

  • Pentacel Vaccine: Important Reminders

    To: Ottawa Physicians and Nurse Practitioners  
    Date: July 16, 2025
    From: Dr. Laura Bourns, Deputy Medical Officer of Health
    Subject: Pentacel Vaccine: Important Reminders

    Dear Colleagues,

    Since the program transition for DTaP-IPV-Hib vaccination from Pediacel® to Pentacel® in July 2024, the manufacturer, Sanofi, has received pharmacovigilance reports of mixing errors with Pentacel®.

  • Vector-borne disease testing changes at PHOL

    To: Ottawa Physicians and Nurse Practitioners  
    Date: July 10, 2025
    From: Dr. Monir Taha, Associate Medical Officer of Health
    Subject: Vector-borne disease testing changes at PHOL

    Dear Colleagues,

    Public Health Ontario Laboratory (PHOL) has recently updated its testing protocols for vector-borne disease testing.

Welcome to the new OttawaPublicHealth.ca

Ottawa Public Health has moved to a refreshed website. During this transition, some links, redirects, documents, pages or display features may be temporarily affected.

Your feedback will help us review and address issues during the stabilization period.